Keywords: |
nonhuman; solid tumor; note; evidence based medicine; cd3 antigen; cd8 antigen; cell proliferation; t lymphocyte; antigens, cd3; t-lymphocytes; animals; mice; cell survival; cell function; interleukin 2; cancer immunotherapy; gene expression; cell growth; in vivo study; antineoplastic activity; cell line, tumor; tumor antigen; mice, transgenic; lymphocyte activation; immune response; antigen; drug mechanism; immunogenicity; leukemia, myeloid; neoplasms, experimental; cell migration; cell activation; adoptive immunotherapy; immunotherapy, adoptive; antigens, cd28; cell transfer; interleukin-2; acute disease; ovalbumin
|